Role of neuronal nitric oxide synthase in the antiallodynic effects of intrathecal EGCG in a neuropathic pain rat model

Neuroscience Letters

Volumn 510, Issue 1, 2012, Pages 53-57

  Choi, Jeong Il ^a   Kim, Woong Mo ^a   Lee, Hyung Gon ^a   Kim, Yeo Ok ^a   Yoon, Myung Ha ^a  

^a Chonnam National University   (South Korea)

Author keywords

Antiallodynia; EGCG; Neuropathic pain; Nitric oxide synthase; Spinal cord

Indexed keywords

ARGININE; EPIGALLOCATECHIN GALLATE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; INTERMETHOD COMPARISON; MALE; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; SPINAL NERVE;

ANIMALS; ARGININE; CATECHIN; DISEASE MODELS, ANIMAL; EXTREMITIES; HYPERALGESIA; INJECTIONS, SPINAL; LIGATION; MALE; NEURALGIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL NERVES;

EID: 84862831142     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.12.070     Document Type: Article

References (38)

1. Bryan N.S., Bian K., Murad F. Discovery of the nitric oxide signaling pathway and targets for drug development. Front. Biosci. 2009, 14:1-18.
2. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 1994, 53:55-63.
3. Chen D., Milacic V., Chen M.S., Wan S.B., Lam W.H., Huo C., Landis-Piwowar K.R., Cui Q.C., Wali A., Chan T.H., Dou Q.P. Tea polyphenols, their biological effects and potential molecular targets. Histol. Histopathol. 2008, 4:487-496.
4. Cury Y., Picolo G., Gutierrez V.P., Ferreira S.H. Pain and analgesia: the dual effect of nitric oxide in the nociceptive system. Nitric Oxide 2011, 3:243-254.
5. De Alba J., Clayton N.M., Collins S.D., Colthup P., Chessell I., Knowles R.G. GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain. Pain 2006, 120:170-181.
6. Ebner F.H., Mariotto S., Darra E., Suzuki H., Cavalieri E. Use of STAT1 inhibitors in the treatment of brain I/R injury and neurodegenerative diseases. Cent. Nerv. Syst. Agents Med. Chem. 2011, 11:2-7.
7. Graham H.N. Green tea composition, consumption, and polyphenol chemistry. Prev. Med. 1992, 21:334-350.
8. Guan Y., Yaster M., Raja S.N., Tao Y.X. Genetic knockout and pharmacologic inhibition of neuronal nitric oxide synthase attenuate nerve injury-induced mechanical hypersensitivity in mice. Mol. Pain 2007, 3:29.
9. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo?. Free Radic. Res. 1996, 25:439-454.
10. Kaur S., Anurag A., Tirkey N., Chopra K. Reversal of LPS-induced central and peripheral hyperalgesia by green tea extract. Phytother. Res. 2005, 19:39-43.
11. Khalatbary A.R., Ahmadvand H. Anti-inflammatory effect of the epigallocatechin gallate following spinal cord trauma in rat. Iran Biomed. J. 2011, 15:31-37.
12. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50:355-363.
13. Kim J.S., Kim J.M., Jeong-Ja O, Jeon B.S. Inhibition of inducible nitric oxide synthase expression and cell death by (-)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J. Clin. Neurosci. 2010, 17:1165-1168.
14. Kim C.Y., Lee C., Park G.H., Jang J.H. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity. Arch. Pharm. Res. 2009, 32:869-881.
15. Knowles R.G., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 1994, 298:249-258.
16. Levites Y., Amit T., Youdim M.B., Mandel S. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin-3-gallate neuroprotective action. J. Biol. Chem. 2002, 277:30574-30580.
17. Levites Y., Weinreb O., Maor G., Youdim M.B., Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem. 2001, 78:1073-1082.
18. Li R., Huang Y.G., Fang D., Le W.D. (-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J. Neurosci. Res. 2004, 78:723-731.
19. Lin Y.L., Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol. Pharmacol. 1997, 52:465-472.
20. Mandel S.A., Avramovich-Tirosh Y., Reznichenko L., Zheng H., Weinreb O., Amit T., Youdim M.B. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals 2005, 14:46-60.
21. Mandel S., Youdim M.B. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic. Biol. Med. 2004, 37:304-317.
22. Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993, 52:127-136.
23. Peng P.H., Chiou L.F., Chao H.M., Lin S., Chen C.F., Liu J.H., Ko M.L. Effects of epigallocatechin-3-gallate on rat retinal ganglion cells after optic nerve axotomy. Exp. Eye Res. 2010, 90:528-534.
24. Peng P.H., Ko M.L., Chen C.F. Epigallocatechin-3-gallate reduces retinal ischemia/reperfusion injury by attenuating neuronal nitric oxide synthase expression and activity. Exp. Eye Res. 2008, 86:637-646.
25. Punathil T., Tollefsbol T.O., Katiyar S.K. EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase. Biochem. Biophys. Res. Commun. 2008, 375:162-167.
26. Renno W.M., Saleh F., Klepacek I., Al-Khaledi G., Ismael H., Asfar S. Green tea pain modulating effect in sciatic nerve chronic constriction injury rat model. Nutr. Neurosci. 2006, 9:41-47.
27. Singal A., Anjaneyulu M., Chopra K. Modulatory role of green tea extract on antinociceptive effect of morphine in diabetic mice. J. Med. Food 2005, 8:386-391.
28. Singh R., Ahmed S., Islam N., Goldberg V.M., Haqqi T.M. Epigallocatechin-3-gallate inhibits interleukin-1 beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum. 2002, 46:2079-2086.
29. Sung C.S., Wen Z.H., Chang W.K., Ho S.T., Tsai S.K., Chang Y.C., Wong C.S. Intrathecal interleukin-1 beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord. Brain Res. 2004, 1015:145-153.
30. Sutherland B.A., Shaw O.M., Clarkson A.N., Jackson D.N., Sammut I.A., Appleton I. Neuroprotective effects of (-)-epigallocatechin gallate following hypoxia-ischemia-induced brain damage: novel mechanisms of action. FASEB J. 2005, 19:258-260.
31. Suzuki M., Tabuchi M., Ikeda M., Umegaki K., Tomita T. Protective effects of green tea catechins on cerebral ischemic damage. Med. Sci. Monit. 2004, 10:166-174.
32. Tanabe M., Nagatani Y., Saitoh K., Takasu K., Ono H. Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice. Neuropharmacology 2009, 56:702-708.
33. Weinreb O., Amit T., Mandel S., Youdim M.B. Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr. 2009, 4:283-296.
34. Wink D.A., Hanbauer I., Grisham M.B., Laval F., Nims R.W., Laval J., Cook J., Pacelli R., Liebmann J., Krishna M., Ford P.C., Mitchell J.B. Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr. Top. Cell. Regul. 1996, 34:159-187.
35. Wei I.H., Tu H.C., Huang C.C., Tsai M.H., Tseng C.Y., Shieh J.Y. (-)-Epigallocatechin gallate attenuates NADPH-d/nNOS expression in motor neurons of rats following peripheral nerve injury. BMC Neurosci. 2011, 12:52.
36. Xu Z., Chen S., Li X., Luo G., Li L., Le W. Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochem. Res. 2006, 31:1263-1269.
37. Yamakuchi M., Bao C., Ferlito M., Lowenstein C.J. Epigallocatechin gallate inhibits endothelial exocytosis. Biol. Chem. 2008, 389:935-941.
38. Zaveri N.T. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci. 2006, 78:2073-2080.